Sepalika a Healthcare content startup raises $750,000 from Accel

Published On 2017-04-29 09:43 GMT   |   Update On 2021-08-17 06:08 GMT
Sepalika, a healthcare content platform has raised $750,000 (Rs 4.8 crore) in seed funding led by venture capital firm Accel Partners. It offers research-based information on diet, lifestyle changes and supplements and helps in prevention and reversing chronic health conditions. The company was founded in 2016 by Sharda Agarwal and Mahesh Jayaraman. Agarwal previously worked with Coca-Cola, MarketGate.It mainly focuses on 11 chronic health conditions such as type-2 diabetes, cardiac diseases, hypertension, arthritis and mental health and depression.

Barath Shankar Subramanian, principal in Accel, said, Sepalika's research-backed content platform aims to bring down the dependence on drugs and partner patients, caregivers, or experts in functional medicine to reverse chronic illnesses.

The firm, owned and operated by Moonjur Healthcare Pvt Ltd., will use the capital to further enhance its platform and strengthen its core proposition, the statement added.

The funds will be deployed towards building the platform and strengthening its core proposition. Sepalika aims to use the fresh capital infused for further building on its research-based content and strengthening its core proposition in the key market of the USA, Sharda Agarwal and Mahesh Jayaraman, Co-Founders, said on Friday.

With this present fund flow he company is planning an advertising model for the content side of its business besides working on making its content available in local Indian languages.
Tags:    
Article Source : ET health world

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News